DeepBiome Therapeutics
Allston
About DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform. The company's drug discovery platform leverages deep learning, microbiome, and synthetic biology technologies, enabling drug companies to release the therapeutic power of the microbiome. It was founded in 2017 and is based in Allston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Last round: Series Unknown (Jul 2019)
- Website: deepbiometherapeutics.com
- Phone: contact@deepbiometherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/deepbiome-therapeutics-425 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.